Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Sudden steep drop in blood pressure on standing from lying down may predict atrial fibrillation

21.11.2013
Johns Hopkins-led study suggests physicians check for heart rhythm disturbance in those with orthostatic hypotension

Results of a Johns Hopkins-led study have identified a possible link between a history of sudden drops in blood pressure and the most common form of irregular heartbeat.

The study suggests that a bout of orthostatic hypotension — a steep blood pressure drop that occurs when a person stands up after a period of lying down — appears to be associated with an overall 40 percent increase in the risk of developing atrial fibrillation over the following two decades.

While a simple, inexpensive doctor's office test can check for orthostatic hypotension, the researchers caution that the condition itself does not generally need treatment, nor have they demonstrated that it is a cause of atrial fibrillation.

They further note that because atrial fibrillation is often present without causing noticeable symptoms, some people may already have the rhythm disturbance before an episode of orthostatic hypotension, though they tried to exclude those subjects from the study.

But the researchers say their findings do suggest the need for further study and that clinicians who diagnose orthostatic hypotension in their patients need to be more vigilant than they otherwise might be in watching out for atrial fibrillation. The arrhythmia is an underdiagnosed condition that increases the risk of stroke fivefold, as well as risks of heart failure and dementia. People with atrial fibrillation are often treated with blood thinners to reduce the risk of stroke, and with other medications that regulate the rate and rhythm of the heartbeat. The findings were published last week in the journal PLOS ONE.

"We hope our research will sensitize physicians to a possible link between orthostatic hypotension and atrial fibrillation, and that they will go the extra step to see if something more serious is going on when patients experience rapid blood pressure fluctuations," says study leader Sunil K. Agarwal, M.D., M.P.H., Ph.D., a fellow in the Division of General Internal Medicine at the Johns Hopkins University School of Medicine. "We want this on their radar screens."

For the study, the researchers followed 12,071 African-American and white men and women ages 45 to 64 years who were enrolled in the Atherosclerosis Risks in Communities (ARIC) study. From 1987 to 1989, each subject had a baseline visit during which information on socioeconomic indicators, medical history, family history, cardiovascular disease risk factors, serum chemistries, electrocardiograms (ECGs), medication use and anthropometrics was collected. Three follow-up visits were conducted, as well as annual telephone interviews and active surveillance of hospitalizations and death.

Five percent of the subjects (603 of them) were diagnosed with a rapid drop in blood pressure when going from lying down to standing up. The authors defined orthostatic hypotension as a 20 mmHg or greater drop in systolic blood pressure or a dip of at least 10 mmHg in diastolic pressure. Those who had a history or symptoms of atrial fibrillation at baseline were excluded from the study.

During an average follow-up of 18.1 years, 1,438 (11.9 percent) of the study participants developed atrial fibrillation. Those with orthostatic hypotension, after accounting for factors such as race, age, gender and other common risk factors for the arrhythmia, were 40 percent more likely than those without orthostatic hypotension to develop an irregular heartbeat. Atrial fibrillation was identified by 12-lead ECGs recorded during three follow-up visits at three-year intervals through 1998, and by hospitalizations and/or death certificates through 2010.

The 40 percent increased risk associated with atrial fibrillation for patients with fluctuating blood pressure was the same increase in risk associated with subjects who had diabetes or high blood pressure.

Atrial fibrillation is the most common type of arrhythmia, or problem with the rate or rhythm of the heart. During an arrhythmia, the heart can beat too fast, too slow or with an irregular rhythm.

Atrial fibrillation affects approximately 3 million people in North America, and the prevalence is projected to double by 2050. It occurs when the upper chambers of the heart, the atria, beat chaotically and usually rapidly out of coordination with the two lower chambers of the organ. During atrial fibrillation episodes, blood may pool inappropriately in the upper chamber, forming clots that can travel to the brain and hindering the healthy function of the heart, Agarwal says.

Blood thinner treatment has been shown to dramatically reduce stroke risk in these patients by more than half, but many don't take the medication because they are unaware they have the condition. Symptoms include heart palpitations, shortness of breath and weakness.

Agarwal says doctors don't routinely test for orthostatic hypotension. It is done by having the patient lie down for two to five minutes while having blood pressure tested several times, then standing up and having the same readings taken again after two minutes. Sometimes a patient with orthostatic hypotension will feel lightheaded and dizzy upon standing, but not always.

"We need more research into whether there is any sort of causal relationship between orthostatic hypotension and atrial fibrillation, or whether it is simply a marker of dysfunction of autonomic nervous system or generally poor health," he says.

This research was sponsored by the National Institutes of Health's National Heart, Lung and Blood Institute (N01-HC-55015, 55016, 55018, 55019, 55020, 55021, and 55022 and T32-HL-007779 and T32HL007024). Additional funding for this study was provided by the American Heart Association (09SDG2280087).

Researchers from the University of Minnesota, the University of North Carolina and Wake Forest University School of Medicine also took part in this study. Other researchers from Johns Hopkins include Seamus P. Whelton, M.D., M.P.H.; Alanna M. Chamberlain, M.P.H., Ph.D.; and Josef Coresh, M.D., M.P.H.

Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is a $6.7 billion integrated global health enterprise and one of the leading academic health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's vision, "Together, we will deliver the promise of medicine," is supported by its mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, and more than 35 Johns Hopkins Community Physicians sites. The Johns Hopkins Hospital, opened in 1889, was ranked number one in the nation for 21 years in a row by U.S. News & World Report. For more information about Johns Hopkins Medicine, its research, education and clinical programs, and for the latest health, science and research news, visit http://www.hopkinsmedicine.org.

Media Contacts:
Stephanie Desmon
410-955-8665; sdesmon1@jhmi.edu
Helen Jones
410-502-9422; hjones49@jhmi.edu

Stephanie Desmon | EurekAlert!
Further information:
http://www.jhmi.edu

More articles from Health and Medicine:

nachricht TSRI researchers develop new method to 'fingerprint' HIV
29.03.2017 | Scripps Research Institute

nachricht Periodic ventilation keeps more pollen out than tilted-open windows
29.03.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Researchers shoot for success with simulations of laser pulse-material interactions

29.03.2017 | Materials Sciences

Igniting a solar flare in the corona with lower-atmosphere kindling

29.03.2017 | Physics and Astronomy

As sea level rises, much of Honolulu and Waikiki vulnerable to groundwater inundation

29.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>